Wikidata entity: Q422188
C₂₄H₃₂O₄S (P274)
Quantities
| P4250 | defined daily dose | 75 |
| P2067 | mass | 416.202 |
| P3780 | active ingredient in | ... | Q47520994 (Aldactone) | Aldactone |
| P233 | canonical SMILES | String | CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C | ??? |
| P373 | Commons category | String | Spironolactone | ??? |
| P1889 | different from | ... | Q25098673 (spirolactone) | spirolactone |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Spironolactone%203D%20ball.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284515 (LiverTox toxicity likelihood category D) | LiverTox toxicity likelihood category D |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P1987 | MCN code | String | 2937.29.50 | ??? |
| P1987 | MCN code | String | 3003.39.94 | ??? |
| P1987 | MCN code | String | 3004.32.20 | ??? |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q486485 (anasarka) | anasarka |
| P2175 | medical condition treated | ... | Q794086 (hypokalemia) | hypokalemia |
| P2175 | medical condition treated | ... | Q1482922 (Conn's syndrome) | Conn's syndrome |
| P2175 | medical condition treated | ... | Q19000661 (congestive heart failure) | congestive heart failure |
| P129 | physically interacts with | ... | Q3454531 (Nuclear receptor subfamily 3 group C member 2) | Nuclear receptor subfamily 3 group C member 2 |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q221520 (triamterene) | triamterene |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q155472 (valsartan) | valsartan |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q733186 (telmisartan) | telmisartan |
| P769 | significant drug interaction | ... | Q415970 (candesartan) | candesartan |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q423804 (eplerenone) | eplerenone |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q425293 (fosinopril) | fosinopril |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422665 (trimethoprim) | trimethoprim |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q410074 (losartan) | losartan |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q947266 (irbesartan) | irbesartan |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P3364 | stereoisomer of | ... | Q82294876 (7|A-Spironolactone) | 7|A-Spironolactone |
| P279 | subclass of | ... | Q27167012 (ethanethioic acid S-(10,13-dimethyl-3,5'-dioxo-7-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]yl) ester) | ethanethioic acid S-(10,13-dimethyl-3,5'-dioxo-7-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]yl) ester |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q200656 (diuretic) | diuretic |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q3290587 (antimineralocorticoid) | antimineralocorticoid |
| P910 | topic's main category | ... | Q65637012 (Category:Spironolactone) | Category:Spironolactone |
Why not click here or view trends?
log id: 2562721